Triple-negative breast cancer (TNBC) is one of the most aggressive and therapeutically challenging breast cancer subtypes, characterized by the absence of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression [1,2]. This evidence concerns the gene ERBB2 and breast cancer.